Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cal-5G Syrup
- Development stage
- Unknown
- Lead developer
- Avogadro
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cal-5G Syrup (also marketed as Cal-5G Suspension) is an oral nutritional supplement developed and marketed by Avogadro. It is formulated as a fixed-dose combination of calcium carbonate, magnesium hydroxide, zinc sulfate, vitamin D3 (cholecalciferol), and vitamin B12 (cyanocobalamin). The supplement is indicated for the prevention and treatment of calcium deficiency, and to support bone and joint health in conditions such as osteoporosis and chronic arthritis, particularly in elderly populations.
- Brand names
- Cal-5G SuspensionCal5G SuspensionCal 5G SuspensionCal-5G SyrupCal5G SyrupCal 5G Syrup
- Other names
- Ca-5G SyrupCa5G SyrupCa 5G Syrup
02
Targets
CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Cal-5G Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cal-5G Syrup.